EUVIMEDEUVIMED entdecken
Crossref

iRGD-Functionalized Graphene–Silver Nanohybrids for Enhanced Blood–Brain Barrier Transport and Tumor Penetration in Glioma Models

Vianni Chopra iD, Jocelyn Alexandra Gómez Siono, Carlos Eduardo Fajardo Barocio iD, Gaurav Chauhan iD

ACS Applied Bio Materials · 02.11.2026 · 9 (21) · 10129-10151

DOI: 10.1021/acsabm.6c00709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 12.10.2026. Verfasst von Vianni Chopra und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering and Sciences, Tecnologico de Monterrey, Av. Eugenio Garza Sada 2501 Sur, Monterrey, NL64849, Mexico. Hauptthemen laut MEDLINE: Glioma, Graphite, Silver, Doxorubicin. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Sistema Nacional de Investigadores, Sistema Nacional de Investigación, Secretaría Nacional de Ciencia, Tecnología e Innovación, Sistema Nacional de Investigaci?n, Secretar?a Nacional de Ciencia, Tecnolog?a e Innovaci?n.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efficient drug delivery across both the tumor microenvironment and the blood–brain barrier (BBB) remains a major challenge in glioblastoma therapy, where dense cellular architecture and endothelial restriction severely limit treatment efficacy. Here, we report the rational design of a multifunctional nanoplatform, Dox[iRGD-GO@AgNP], integrating graphene oxide (GO), silver nanoparticles (AgNPs), and a cyclic iRGD tumor-penetrating peptide to enhance doxorubicin (Dox) transport, tumor penetration, and intracellular delivery. Comprehensive physicochemical characterization confirmed successful synthesis, surface functionalization, colloidal stability, and efficient drug loading. In two-dimensional C6 glioma cell monolayers, cyclic iRGD-functionalized nanohybrids demonstrated significantly enhanced intracellular Dox accumulation compared to free drug and nontargeted controls. These effects were further amplified in three-dimensional glioma spheroids, where Dox[iRGD-GO@AgNP] achieved deep tumor penetration (>80 µm) and more homogeneous intratumoral distribution. Enhanced delivery translated into superior therapeutic efficacy, as evidenced by reduced cell viability, increased membrane damage, upregulation of apoptosis-related markers (p53 and caspase-3 &9), and pronounced morphological disruption confirmed by fluorescence imaging and electron microscopy. To evaluate endothelial transport, a Transwell-based bEnd.3 BBB model was established and validated by transendothelial electrical resistance measurements and tight junction imaging. Cyclic iRGD-functionalized nanohybrids exhibited significantly enhanced transendothelial transport while preserving BBB integrity, indicating ligand-mediated transport rather than nonspecific barrier disruption. Importantly, improved BBB traversal resulted in increased drug accumulation in downstream glioma cells and spheroids. These composites showed anti-angiogenic properties in ovo CAM model. Overall, this study integrates rational nanocomposite design with a hierarchical in vitro evaluation framework spanning material characterization, tumor-relevant 2D and 3D models, and BBB transport. The Dox[iRGD-GO@AgNP] platform addresses key delivery and efficacy barriers in glioblastoma and provides a translationally relevant strategy for the development of BBB-penetrating nanotherapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaGraphiteSilverDoxorubicinBlood-Brain BarrierOligopeptidesMetal NanoparticlesBiocompatible MaterialsAntibiotics, AntineoplasticBrain NeoplasmsAnimalsMaterials TestingHumansRatsParticle SizeCell SurvivalCell Line, TumorDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

BBBDoxorubicingliomagraphene oxideiRGDsilver nanoparticlestumor penetration

Substanzen

GraphiteSilverDoxorubicinOligopeptidesN-end cysteine peptide tumor-homing peptideBiocompatible MaterialsAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • School of Engineering and Sciences, Tecnologico de Monterrey, Av. Eugenio Garza Sada 2501 Sur, Monterrey, NL64849, Mexico.

ORCID-Profile: Vianni Chopra, Carlos Eduardo Fajardo Barocio, Gaurav Chauhan

Förderung

  • Sistema Nacional de Investigadores
  • Sistema Nacional de Investigación, Secretaría Nacional de Ciencia, Tecnología e Innovación
  • Sistema Nacional de Investigaci?n, Secretar?a Nacional de Ciencia, Tecnolog?a e Innovaci?n
  • Semiconductor and Nanotechnology Research Group at Tecnologico de Monterrey

Zitieren

APA

Chopra, V., Siono, J. A. G., Fajardo Barocio, C. E., & Chauhan, G. (2026). iRGD-Functionalized Graphene–Silver Nanohybrids for Enhanced Blood–Brain Barrier Transport and Tumor Penetration in Glioma Models. ACS Applied Bio Materials, 9(21), 10129-10151. https://doi.org/10.1021/acsabm.6c00709

Vancouver

Chopra V, Siono JAG, Fajardo Barocio CE, Chauhan G. iRGD-Functionalized Graphene–Silver Nanohybrids for Enhanced Blood–Brain Barrier Transport and Tumor Penetration in Glioma Models. ACS Applied Bio Materials. 2026;9(21):10129-10151. doi:10.1021/acsabm.6c00709

BibTeX
@article{Chopra2026,
  author = {Chopra, Vianni and Siono, Jocelyn Alexandra Gómez and Fajardo Barocio, Carlos Eduardo and Chauhan, Gaurav},
  title = {iRGD-Functionalized Graphene–Silver Nanohybrids for Enhanced Blood–Brain Barrier Transport and Tumor Penetration in Glioma Models},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  volume = {9},
  number = {21},
  pages = {10129--10151},
  doi = {10.1021/acsabm.6c00709}
}
Kostenlos starten →